{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:44:48Z","timestamp":1794458688293,"version":"4.9.1"},"reference-count":173,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34692","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T06:38:32Z","timestamp":1721111912000},"page":"e34692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance"],"prefix":"10.1016","volume":"10","author":[{"given":"Hiva","family":"Kadkhoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1451-3996","authenticated-orcid":false,"given":"Pourya","family":"Gholizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6026-8795","authenticated-orcid":false,"given":"Hossein","family":"Samadi Kafil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Ghotaslou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Pirzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ahangarzadeh Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edris","family":"Nabizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Feizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Aghazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.heliyon.2024.e34692_bib1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrg3962","article-title":"Horizontal gene transfer: building the web of life","volume":"16","author":"Soucy","year":"2015","journal-title":"Nat. Rev. Genet."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34692_bib2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrmicro1235","article-title":"Mobile genetic elements: the agents of open source evolution","volume":"3","author":"Frost","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e34692_bib3","first-page":"80","article-title":"The role of horizontal gene transfer in antibiotic resistance","volume":"10","author":"Kaplan","year":"2014","journal-title":"Eukaryon"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34692_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tree.2013.04.002","article-title":"Exploring the costs of horizontal gene transfer","volume":"28","author":"Baltrus","year":"2013","journal-title":"Trends Ecol. Evol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib5","doi-asserted-by":"crossref","first-page":"e02406","DOI":"10.1128\/mBio.02406-17","article-title":"CRISPR-Cas-mediated phage resistance enhances horizontal gene transfer by transduction","volume":"9","author":"Watson","year":"2018","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34692_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e14562","article-title":"Microbiota metabolites in the female reproductive system: focused on the short-chain fatty acids","volume":"9","author":"Mirzaei","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e34692_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-virology-031413-085500","article-title":"Remarkable mechanisms in microbes to resist phage infections","volume":"1","author":"Dy","year":"2014","journal-title":"Annual review of virology"},{"issue":"6379","key":"10.1016\/j.heliyon.2024.e34692_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar4120","article-title":"Systematic discovery of antiphage defense systems in the microbial pangenome","volume":"359","author":"Doron","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41564-017-0051-0","article-title":"DISARM is a widespread bacterial defence system with broad anti-phage activities","volume":"3","author":"Ofir","year":"2018","journal-title":"Nature microbiology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/medicina60010130","article-title":"Exploring the interplay of the CRISPR-CAS system with antibiotic resistance in Staphylococcus aureus: a poultry meat study from lahore, Pakistan","volume":"60","author":"Shabbir","year":"2024","journal-title":"Medicina"},{"key":"10.1016\/j.heliyon.2024.e34692_bib11","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.3389\/fmicb.2019.02934","article-title":"CRISPR-cas system in antibiotic resistance plasmids in Klebsiella pneumoniae","volume":"10","author":"Kamruzzaman","year":"2019","journal-title":"Front. Microbiol."},{"issue":"7571","key":"10.1016\/j.heliyon.2024.e34692_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature15386","article-title":"CRISPR-Cas immunity in prokaryotes","volume":"526","author":"Marraffini","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s12879-024-09451-5","article-title":"Prevalence of the CRISPR-cas system and its association with antibiotic resistance in clinical Klebsiella pneumoniae isolates","volume":"24","author":"Kadkhoda","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e34692_bib14","series-title":"Establishment of Type Iv Crispr for Genome Editing in Human Cells","author":"Ponomariova","year":"2023"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41564-022-01265-y","article-title":"Evolution of CRISPR-associated endonucleases as inferred from resurrected proteins","volume":"8","author":"Alonso-Lerma","year":"2023","journal-title":"Nature Microbiology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34692_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12033-022-00567-0","article-title":"A review on the mechanism and applications of CRISPR\/Cas9\/Cas12\/Cas13\/Cas14 proteins utilized for genome engineering","volume":"65","author":"Hillary","year":"2023","journal-title":"Mol. Biotechnol."},{"issue":"7432","key":"10.1016\/j.heliyon.2024.e34692_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nature11723","article-title":"Bacteriophage genes that inactivate the CRISPR\/Cas bacterial immune system","volume":"493","author":"Bondy-Denomy","year":"2013","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34692_bib18","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3390\/ph15121498","article-title":"CRISPR-Cas system: a tool to eliminate drug-resistant gram-negative bacteria","volume":"15","author":"Kundar","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34692_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/antibiotics9020065","article-title":"Strategies to combat multidrug-resistant and persistent infectious diseases","volume":"9","author":"Pacios","year":"2020","journal-title":"Antibiotics"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib20","first-page":"226","article-title":"Dissemination of carbapenemases producing Gram negative bacteria in the Middle East","volume":"7","author":"Bialvaei","year":"2015","journal-title":"Iran. J. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e34692_bib21","first-page":"1","article-title":"Health literacy, knowledge, household disposal, and misuse practices of antibiotics among UAE residents: a nationwide cross-sectional study","author":"Kharaba","year":"2023","journal-title":"Expert Rev. Anti-infect. Ther."},{"key":"10.1016\/j.heliyon.2024.e34692_bib22","first-page":"1097","article-title":"Over-and misuse of antibiotics and the clinical consequence in necrotizing pancreatitis: an observational multicenter study","volume":"10","author":"Timmerhuis","year":"2023","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-019-1687-0","article-title":"Exploring the antimicrobial resistance profiles of WHO critical priority list bacterial strains","volume":"19","author":"Havenga","year":"2019","journal-title":"BMC Microbiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/1973947815Y.0000000063","article-title":"Current methods for the identification of carbapenemases","volume":"28","author":"Bialvaei","year":"2016","journal-title":"J. Chemother."},{"key":"10.1016\/j.heliyon.2024.e34692_bib25","series-title":"Tackling Drug-Resistant Infections Globally: Final Report and Recommendations","author":"O'Neill","year":"2016"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.coph.2011.06.011","article-title":"At least it won't hurt: the personal risks of antibiotic exposure","volume":"11","author":"Stewardson","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e34692_bib27","first-page":"1","article-title":"Postbiotics versus probiotics in early-onset colorectal cancer","author":"Feizi","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/08850666221102796","article-title":"Interaction between altered gut microbiota and sepsis: a hypothesis or an authentic fact?","volume":"38","author":"Nabizadeh","year":"2023","journal-title":"J. Intensive Care Med."},{"key":"10.1016\/j.heliyon.2024.e34692_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.127245","article-title":"The metabolic, protective, and immune functions of Akkermansia muciniphila","volume":"266","author":"Ghotaslou","year":"2023","journal-title":"Microbiol. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34692_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: an alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Therapeut"},{"issue":"23","key":"10.1016\/j.heliyon.2024.e34692_bib31","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1073\/pnas.1500107112","article-title":"Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria","volume":"112","author":"Yosef","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib32","article-title":"Zinc finger nuclease: a new approach to overcome beta-lactam antibiotic resistance","volume":"9","author":"Dastjerdeh","year":"2016","journal-title":"Jundishapur J. Microbiol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e34692_bib33","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1172\/JCI72992","article-title":"Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9","volume":"124","author":"Gupta","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e34692_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103907","article-title":"Antisense peptide nucleic acids againstftsZ andefaA genes inhibit growth and biofilm formation of Enterococcus faecalis","volume":"139","author":"Narenji","year":"2020","journal-title":"Microb. Pathog."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34692_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.biomaterials.2011.09.075","article-title":"Antisense inhibition of gene expression and growth in gram-negative bacteria by cell-penetrating peptide conjugates of peptide nucleic acids targeted to rpoD gene","volume":"33","author":"Bai","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.heliyon.2024.e34692_bib36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.biopha.2017.06.092","article-title":"Peptide nucleic acids (PNAs): currently potential bactericidal agents","volume":"93","author":"Narenji","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34692_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.synbio.2018.09.004","article-title":"CRISPR-Cas9\/Cas12a biotechnology and application in bacteria","volume":"3","author":"Yao","year":"2018","journal-title":"Synthetic and systems biotechnology"},{"key":"10.1016\/j.heliyon.2024.e34692_bib38","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.2147\/IDR.S370869","article-title":"The application of the CRISPR-Cas system in antibiotic resistance","author":"Tao","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.heliyon.2024.e34692_bib39","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.csbj.2020.08.031","article-title":"CRISPR-Cas systems: overview, innovations and applications in human disease research and gene therapy","volume":"18","author":"Xu","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34692_bib40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/pharmaceutics13030352","article-title":"Novel strategy to combat antibiotic resistance: a sight into the combination of CRISPR\/Cas9 and nanoparticles","volume":"13","author":"Wan","year":"2021","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34692_bib41","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3390\/antibiotics12061075","article-title":"CRISPR-Cas9 system: a prospective pathway toward combatting antibiotic resistance","volume":"12","author":"Javed","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.heliyon.2024.e34692_bib42","series-title":"The CRISPR-Cas Technology: Trends in Healthcare. CRISPR-Cas System in Translational Biotechnology","first-page":"109","author":"Chawla","year":"2024"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41592-020-0771-6","article-title":"Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies","volume":"17","author":"Marino","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.heliyon.2024.e34692_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.126963","article-title":"Anti-CRISPR proteins as a therapeutic agent against drug-resistant bacteria","volume":"257","author":"Vyas","year":"2022","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.heliyon.2024.e34692_bib45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cofs.2021.02.016","article-title":"Advances in bacteriophage-mediated control strategies to reduce bacterial virulence","volume":"41","author":"Easwaran","year":"2021","journal-title":"Curr. Opin. Food Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2958.2010.07452.x","article-title":"Dynamic properties of the Sulfolobus CRISPR\/Cas and CRISPR\/Cmr systems when challenged with vector\u2010borne viral and plasmid genes and protospacers","volume":"79","author":"Gudbergsdottir","year":"2011","journal-title":"Mol. Microbiol."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e34692_bib47","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1093\/nar\/gkr606","article-title":"The Streptococcus thermophilus CRISPR\/Cas system provides immunity in Escherichia coli","volume":"39","author":"Sapranauskas","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e26809","article-title":"CRISPR-like sequences association with antibiotic resistance and biofilm formation in Helicobacter pylori clinical isolates","volume":"10","author":"Yousefi","year":"2024","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34692_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225131","article-title":"CRISPR-Cas influences the acquisition of antibiotic resistance in Klebsiella pneumoniae","volume":"14","author":"Mackow","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e34692_bib50","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2147\/IDR.S253380","article-title":"Association of CRISPR\/Cas system with the drug resistance in Klebsiella pneumoniae","volume":"13","author":"Wang","year":"2020","journal-title":"Infect. Drug Resist."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34692_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00064-16","article-title":"CRISPR-Cas and restriction-modification act additively against conjugative antibiotic resistance plasmid transfer in Enterococcus faecalis","volume":"1","author":"Price","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.heliyon.2024.e34692_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-021-00455-6","article-title":"Role of CRISPR-Cas system on antibiotic resistance patterns of Enterococcus faecalis","volume":"20","author":"Gholizadeh","year":"2021","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib53","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.mib.2010.08.004","article-title":"Horizontal gene transfer and the genomics of enterococcal antibiotic resistance","volume":"13","author":"Palmer","year":"2010","journal-title":"Curr. Opin. Microbiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34692_bib54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/pathogens10020205","article-title":"Genomic and phenotypic analysis of multidrug-resistant Acinetobacter baumannii clinical isolates carrying different types of CRISPR\/Cas systems","volume":"10","author":"Tyumentseva","year":"2021","journal-title":"Pathogens"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib55","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jam.14409","article-title":"Clonal relatedness and resistance characteristics of OXA\u201024 and\u201058 producing carbapenem\u2010resistant Acinetobacter baumannii isolates in Tehran, Iran","volume":"127","author":"Salehi","year":"2019","journal-title":"J. Appl. Microbiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/lambio\/ovae003","article-title":"The CRISPR\u2013Cas system in clinical strains of Acinetobacter baumannii: an in-silico analysis","volume":"77","author":"Mart\u00ednez-Trejo","year":"2024","journal-title":"Lett. Appl. Microbiol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34692_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00829-22","article-title":"CRISPR-cas in acinetobacter baumannii contributes to antibiotic susceptibility by targeting endogenous AbaI","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e34692_bib66","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2217\/fmb-2018-0234","article-title":"The CRISPR-cas system promotes antimicrobial resistance in Campylobacter jejuni","volume":"13","author":"Shabbir","year":"2018","journal-title":"Future Microbiol."},{"issue":"30","key":"10.1016\/j.heliyon.2024.e34692_bib65","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.1073\/pnas.1323025111","article-title":"A CRISPR-Cas system enhances envelope integrity mediating antibiotic resistance and inflammasome evasion","volume":"111","author":"Sampson","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2024.e34692_bib163","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9080396","article-title":"CRISPR-Cas system: an adaptive immune system's association with antibiotic resistance in Salmonella enterica serovar enteritidis","volume":"2022","author":"Haider","year":"2022","journal-title":"BioMed Res. Int."},{"issue":"1772","key":"10.1016\/j.heliyon.2024.e34692_bib68","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2018.0384","article-title":"Genome-wide correlation analysis suggests different roles of CRISPR-Cas systems in the acquisition of antibiotic resistance genes in diverse species","volume":"374","author":"Shehreen","year":"2019","journal-title":"Philosophical Transactions of the Royal Society B"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib164","doi-asserted-by":"crossref","first-page":"e00309","DOI":"10.1128\/mBio.00309-12","article-title":"An evolutionary link between natural transformation and CRISPR adaptive immunity","volume":"3","author":"Jorth","year":"2012","journal-title":"mBio"},{"issue":"1842","key":"10.1016\/j.heliyon.2024.e34692_bib69","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2020.0464","article-title":"CRISPR-Cas is associated with fewer antibiotic resistance genes in bacterial pathogens","volume":"377","author":"Pursey","year":"2022","journal-title":"Philosophical Transactions of the Royal Society B"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34692_bib165","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01796-15","article-title":"Phylogenetic distribution of CRISPR-Cas systems in antibiotic-resistant Pseudomonas aeruginosa","volume":"6","author":"van Belkum","year":"2015","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34692_bib60","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/jac\/dkx137","article-title":"Presence of Type IF CRISPR\/Cas systems is associated with antimicrobial susceptibility in Escherichia coli","volume":"72","author":"Aydin","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.heliyon.2024.e34692_bib166","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7861695","article-title":"The Mycobacterium tuberculosis CRISPR-associated Cas1 involves persistence and tolerance to anti-tubercular drugs","volume":"2019","author":"Wei","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34692_bib167","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/15476286.2019.1582974","article-title":"CRISPR-Cas in Streptococcus pyogenes","volume":"16","author":"Le Rhun","year":"2019","journal-title":"RNA Biol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34692_bib74","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/ismej.2015.20","article-title":"No evidence of inhibition of horizontal gene transfer by CRISPR\u2013Cas on evolutionary timescales","volume":"9","author":"Gophna","year":"2015","journal-title":"ISME J."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34692_bib168","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ijmm.2016.08.005","article-title":"Identification and functional study of type III-A CRISPR-Cas systems in clinical isolates of Staphylococcus aureus","volume":"306","author":"Cao","year":"2016","journal-title":"International Journal of Medical Microbiology"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34692_bib58","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1099\/mic.0.060814-0","article-title":"Antibiotic resistance plasmids spread among natural isolates of Escherichia coli in spite of CRISPR elements","volume":"158","author":"Touchon","year":"2012","journal-title":"Microbiology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34692_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011126","article-title":"The small, slow and specialized CRISPR and anti-CRISPR of Escherichia and Salmonella","volume":"5","author":"Touchon","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34692_bib61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12602-017-9255-0","article-title":"Lactobacillus plantarum as a probiotic potential from kouzeh cheese (traditional Iranian cheese) and its antimicrobial activity","volume":"9","author":"Jabbari","year":"2017","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34692_bib62","first-page":"476","article-title":"Detection of CRISPR and its relationship to drug resistance in Shigella","volume":"55","author":"Wang","year":"2015","journal-title":"Wei Sheng wu xue bao= Acta Microbiologica Sinica"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e34692_bib63","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/JB.01307-10","article-title":"CRISPR distribution within the Escherichia coli species is not suggestive of immunity-associated diversifying selection","volume":"193","author":"Touchon","year":"2011","journal-title":"J. Bacteriol."},{"issue":"null","key":"10.1016\/j.heliyon.2024.e34692_bib64","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.2147\/IDR.S370869","article-title":"The application of the CRISPR-cas system in antibiotic resistance","volume":"15","author":"Tao","year":"2022","journal-title":"Infect. Drug Resist."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34692_bib67","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1086\/319760","article-title":"Campylobacter jejuni infections: update on emerging issues and trends","volume":"32","author":"Acheson","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"7855","key":"10.1016\/j.heliyon.2024.e34692_bib70","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41586-021-03440-3","article-title":"Type III-A CRISPR immunity promotes mutagenesis of staphylococci","volume":"592","author":"Mo","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrmicro.2017.120","article-title":"Anti-CRISPR: discovery, mechanism and function","volume":"16","author":"Pawluk","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib72","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftac039","article-title":"Phages, anti-CRISPR proteins, and drug-resistant bacteria: what do we know about this triad?","volume":"80","author":"Ceballos-Garzon","year":"2022","journal-title":"Pathogens and Disease"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34692_bib73","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41564-020-0692-2","article-title":"Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer","volume":"5","author":"Mahendra","year":"2020","journal-title":"Nature microbiology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34692_bib75","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cell.2018.06.013","article-title":"Bacteriophage cooperation suppresses CRISPR-Cas3 and Cas9 immunity","volume":"174","author":"Borges","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e34692_bib76","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-genet-120417-031321","article-title":"Phage-encoded anti-CRISPR defenses","volume":"52","author":"Stanley","year":"2018","journal-title":"Annu. Rev. Genet."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib77","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1073\/pnas.1617415113","article-title":"Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system","volume":"114","author":"H\u00f8yland-Kroghsbo","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib78","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.gene.2015.03.062","article-title":"Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: a meta-analysis","volume":"565","author":"Hou","year":"2015","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib79","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/bit.25851","article-title":"Current and future prospects for CRISPR-based tools in bacteria","volume":"113","author":"Luo","year":"2016","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.heliyon.2024.e34692_bib80","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3389\/fmicb.2017.00812","article-title":"A novel and efficient method for bacteria genome editing employing both CRISPR\/Cas9 and an antibiotic resistance cassette","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34692_bib81","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41565-021-00854-y","article-title":"Nanotechnology to advance CRISPR-Cas genetic engineering of plants","volume":"16","author":"Demirer","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34692_bib82","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/plphys\/kiac027","article-title":"Expanding the plant genome editing toolbox with recently developed CRISPR\u2013Cas systems","volume":"188","author":"Wada","year":"2022","journal-title":"Plant Physiol."},{"issue":"20","key":"10.1016\/j.heliyon.2024.e34692_bib83","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1016\/j.molcel.2021.08.008","article-title":"Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing","volume":"81","author":"Xu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.heliyon.2024.e34692_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.11.001","article-title":"Sensitizing pathogens to antibiotics using the CRISPR-Cas system","volume":"30","author":"Goren","year":"2017","journal-title":"Drug Resist. Updates"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-019-0317-x","article-title":"CRISPR-cas system: biological function in microbes and its use to treat antimicrobial resistant pathogens","volume":"18","author":"Shabbir","year":"2019","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.heliyon.2024.e34692_bib86","series-title":"Third International Conference on Biological Engineering and Medical Science (ICBioMed2023)","article-title":"Application of CRISPR technology in the prevention and control of bacterial drug resistance","year":"2024"},{"key":"10.1016\/j.heliyon.2024.e34692_bib87","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mib.2017.05.008","article-title":"Diversity, classification and evolution of CRISPR-Cas systems","volume":"37","author":"Koonin","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e34692_bib88","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2147\/IJN.S453566","article-title":"Recent advances in understanding the molecular mechanisms of multidrug resistance and novel approaches of CRISPR\/Cas9-Based genome-editing to combat this health emergency","author":"Allemailem","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib89","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.celrep.2019.01.024","article-title":"sgRNA sequence motifs blocking efficient CRISPR\/Cas9-Mediated gene editing","volume":"26","author":"Graf","year":"2019","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34692_bib90","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e34692_bib91","series-title":"Prediction of Protospacer Adjacent Motif (PAM) Dependencies in CRISPR-Cas9 Systems and Design of Novel Cas9 with Broad PAM Compatibility","author":"Pham","year":"2023"},{"key":"10.1016\/j.heliyon.2024.e34692_bib92","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41467-018-04252-2","article-title":"The CRISPR tool kit for genome editing and beyond","volume":"9","author":"Adli","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34692_bib93","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1007\/s11033-022-07880-6","article-title":"CRISPR\/Cas9 system: a reliable and facile genome editing tool in modern biology","volume":"49","author":"Javaid","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34692_bib94","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/bios14040194","article-title":"A CRISPR\/Cas12a-Based system for sensitive detection of antimicrobial-resistant genes in carbapenem-resistant enterobacterales","volume":"14","author":"Shin","year":"2024","journal-title":"Biosensors"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-020-00795-6","article-title":"CRISPR-Cas system: a potential alternative tool to cope antibiotic resistance","volume":"9","author":"Aslam","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.heliyon.2024.e34692_bib96","article-title":"Exploiting crispr-cas system to combat antibiotic resistance","author":"Geinoro","year":"2024","journal-title":"Review"},{"key":"10.1016\/j.heliyon.2024.e34692_bib97","unstructured":"Preethi C, Gopal S. A Comprehensive Review: CRISPR-Cas9 and dCas9 Strategies in Mitigating Antimicrobial Resistance in Staphylococcus aureus."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-01132-8","article-title":"Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections","volume":"19","author":"Wu","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34692_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009672","article-title":"CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria","volume":"17","author":"Palacios Araya","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2024.e34692_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ggedit.2024.100031","article-title":"Antimicrobial Resistance (AMR) management using CRISPR-Cas based genome editing","author":"Sen","year":"2024","journal-title":"Gene and Genome Editing"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34692_bib103","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4014\/jmb.1508.08080","article-title":"CRISPR\/Cas9-mediated re-sensitization of antibiotic-resistant Escherichia coli harboring extended-spectrum \u03b2-lactamases","volume":"26","author":"Kim","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34692_bib169","doi-asserted-by":"crossref","first-page":"e00113","DOI":"10.1128\/AAC.00113-19","article-title":"Application of CRISPR\/Cas9-based genome editing in studying the mechanism of pandrug resistance in Klebsiella pneumoniae","volume":"63","author":"Sun","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2024.e34692_bib170","article-title":"AMR gene removal by conjugative delivery of CRISPR-Cas9","author":"S\u00fcnderhauf","year":"2019","journal-title":"Microbiology Society"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34692_bib105","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01454-19","article-title":"Conjugative delivery of CRISPR-Cas9 for the selective depletion of antibiotic-resistant enterococci","volume":"63","author":"Rodrigues","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2024.e34692_bib107","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2147\/IDR.S244885","article-title":"Reversal of mcr-1-mediated colistin resistance in Escherichia coli by CRISPR-Cas9 system","volume":"13","author":"Wan","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.heliyon.2024.e34692_bib104","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jare.2019.01.011","article-title":"Reversal of carbapenem-resistance in Shewanella algae by CRISPR\/Cas9 genome editing","volume":"18","author":"Wu","year":"2019","journal-title":"J. Adv. Res."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34692_bib110","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00843-20","article-title":"CRISPR-Cas9-Mediated carbapenemase gene and plasmid curing in carbapenem-resistant Enterobacteriaceae","volume":"64","author":"Hao","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib121","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00928-13","article-title":"Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems","volume":"5","author":"Gomaa","year":"2014","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib119","first-page":"1","article-title":"Genetic engineering of a temperate phage-based delivery system for CRISPR\/Cas9 antimicrobials against Staphylococcus aureus","volume":"7","author":"Park","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib122","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/s41467-020-16731-6","article-title":"Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria","volume":"11","author":"Kiga","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34692_bib120","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00019-20","article-title":"In vivo targeting of Clostridioides difficile using phage-delivered CRISPR-Cas3 antimicrobials","volume":"11","author":"Selle","year":"2020","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34692_bib171","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nbt.3043","article-title":"Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases","volume":"32","author":"Bikard","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e34692_bib172","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3389\/fmicb.2019.02471","article-title":"Endogenous CRISPR-Cas system-based genome editing and antimicrobials: review and prospects","volume":"10","author":"Li","year":"2019","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34692_bib173","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/nbt.3011","article-title":"Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases","volume":"32","author":"Citorik","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e34692_bib101","article-title":"Precision genome editing unveils a breakthrough in reversing antibiotic resistance: CRISPR\/Cas9 targeting of multi-drug resistance genes in methicillin-resistant Staphylococcus aureus","author":"Ates","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.heliyon.2024.e34692_bib102","series-title":"Can CRISPR\/CAS Help Fight Multidrug Resistance (MDR) Bacterial Infections? Gene Editing in Plants: CRISPR-Cas and its Applications","first-page":"95","author":"Kumar","year":"2024"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2018.09.017","article-title":"Exploiting a conjugative CRISPR\/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli","volume":"53","author":"Dong","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34692_bib108","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1093\/jac\/dkz246","article-title":"Eliminating mcr-1-harbouring plasmids in clinical isolates using the CRISPR\/Cas9 system","volume":"74","author":"Wang","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34692_bib109","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e34692_bib111","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/pharmaceutics13030352","article-title":"Novel strategy to combat antibiotic resistance: a sight into the combination of CRISPR\/cas9 and nanoparticles","volume":"13","author":"Wan","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34692_bib112","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00113-19","article-title":"Application of CRISPR\/Cas9-based genome editing in studying the mechanism of pandrug resistance in Klebsiella pneumoniae","volume":"63","author":"Sun","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib113","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/dku323","article-title":"The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae","volume":"70","author":"Poirel","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106475","article-title":"Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy","volume":"59","author":"Yeh","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34692_bib115","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/acs.bioconjchem.6b00676","article-title":"Nonviral genome editing based on a polymer-derivatized CRISPR nanocomplex for targeting bacterial pathogens and antibiotic resistance","volume":"28","author":"Kang","year":"2017","journal-title":"Bioconjugate Chem."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib116","first-page":"691","article-title":"Characterization of biofilm formation and virulence factors of Staphylococcus aureus isolates from paediatric patients in Tehran, Iran","volume":"23","author":"Kadkhoda","year":"2020","journal-title":"Iran J Basic Med Sci"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34692_bib117","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nbt.3043","article-title":"Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials","volume":"32","author":"Bikard","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e34692_bib118","series-title":"Handbook on Antimicrobial Resistance: Current Status, Trends in Detection and Mitigation Measures","first-page":"1","article-title":"CRISPR and CAS editing tools employent in the control of AMR pathogens","author":"Nayakvadi","year":"2023"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34692_bib123","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01300-22","article-title":"Pathogen-specific bactericidal method mediated by conjugative delivery of CRISPR-Cas13a targeting bacterial endogenous transcripts","volume":"10","author":"Song","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.heliyon.2024.e34692_bib124","first-page":"2021","article-title":"CRISPR\/Cas: advances, limitations, and applications for precision cancer research [internet]","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.heliyon.2024.e34692_bib125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2022.01.013","article-title":"Delivery of CRISPR-Cas tools for in vivo genome editing therapy: trends and challenges","volume":"342","author":"Taha","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2024.e34692_bib126","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3389\/fonc.2020.01387","article-title":"CRISPR gene therapy: applications, limitations, and implications for the future","volume":"10","author":"Uddin","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e34692_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1376509","article-title":"Advances and challenges of genome engineering tools in healthcare: molecular insights into CRISPR\/Cas technology","volume":"11","author":"Kumar","year":"2024","journal-title":"Front. Mol. Biosci."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e34692_bib128","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1111\/febs.13760","article-title":"Off\u2010target effects of engineered nucleases","volume":"283","author":"Yee","year":"2016","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib129","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nchembio.1793","article-title":"Small molecule\u2013triggered Cas9 protein with improved genome-editing specificity","volume":"11","author":"Davis","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.heliyon.2024.e34692_bib130","article-title":"CRISPR\/Cas: advances, limitations, and applications for precision cancer research","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Med."},{"issue":"7676","key":"10.1016\/j.heliyon.2024.e34692_bib131","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature24268","article-title":"Enhanced proofreading governs CRISPR\u2013Cas9 targeting accuracy","volume":"550","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"7699","key":"10.1016\/j.heliyon.2024.e34692_bib132","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature26155","article-title":"Evolved Cas9 variants with broad PAM compatibility and high DNA specificity","volume":"556","author":"Hu","year":"2018","journal-title":"Nature"},{"issue":"144","key":"10.1016\/j.heliyon.2024.e34692_bib133","doi-asserted-by":"crossref","DOI":"10.3791\/59202","article-title":"Using Sniper-Cas9 to minimize off-target effects of CRISPR-Cas9 without the loss of on-target activity via directed evolution","author":"Lee","year":"2019","journal-title":"JoVE"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib134","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1038\/s41467-018-05477-x","article-title":"Directed evolution of CRISPR-Cas9 to increase its specificity","volume":"9","author":"Lee","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib135","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41589-020-0490-4","article-title":"Bridge helix arginines play a critical role in Cas9 sensitivity to mismatches","volume":"16","author":"Bratovi\u010d","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34692_bib136","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e34692_bib137","first-page":"173","article-title":"Multidrug-resistant microbial therapy using antimicrobial peptides and the CRISPR\/Cas9 system","author":"Getahun","year":"2022","journal-title":"Vet. Med. Res. Rep."},{"key":"10.1016\/j.heliyon.2024.e34692_bib138","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.11243.1","article-title":"In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease","volume":"6","author":"Lau","year":"2017","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib139","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv."},{"issue":"6488","key":"10.1016\/j.heliyon.2024.e34692_bib140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.aba8853","article-title":"Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants","volume":"368","author":"Walton","year":"2020","journal-title":"Science"},{"issue":"7530","key":"10.1016\/j.heliyon.2024.e34692_bib141","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature13769","article-title":"Programmable RNA recognition and cleavage by CRISPR\/Cas9","volume":"516","author":"O'Connell","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e34692_bib142","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32724","article-title":"RNA-dependent RNA targeting by CRISPR-Cas9","volume":"7","author":"Strutt","year":"2018","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34692_bib143","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2018.02.033","article-title":"Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors","volume":"173","author":"Konermann","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib144","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nmeth.4681","article-title":"CRISPR\u2013Cas goes RNA","volume":"15","author":"Larochelle","year":"2018","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34692_bib145","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s12033-021-00340-9","article-title":"CRISPR: the multidrug resistance endgame?","volume":"63","author":"Shukla","year":"2021","journal-title":"Mol. Biotechnol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34692_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17880","article-title":"The profile of key gut microbiota members and short-chain fatty acids in patients with sepsis","volume":"9","author":"Nabizadeh","year":"2023","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34692_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006990","article-title":"CRISPR-Cas antimicrobials: challenges and future prospects","volume":"14","author":"Pursey","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2024.e34692_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12896-020-00626-x","article-title":"Efficient CRISPR\/Cas9 genome editing in a salmonid fish cell line using a lentivirus delivery system","volume":"20","author":"Gratacap","year":"2020","journal-title":"BMC Biotechnol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib149","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.119.042476","article-title":"In vivo AAV-CRISPR\/Cas9\u2013mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia","volume":"141","author":"Zhao","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2024.e34692_bib150","article-title":"Nanoparticles-mediated CRISPR\/Cas9 delivery: recent advances in cancer treatment","volume":"56","author":"Aghamiri","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.heliyon.2024.e34692_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101482","article-title":"Nano-vectors for CRISPR\/Cas9-mediated genome editing","volume":"44","author":"Yang","year":"2022","journal-title":"Nano Today"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34692_bib152","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1021\/acs.nanolett.7b02664","article-title":"Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA","volume":"17","author":"Patel","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.heliyon.2024.e34692_bib153","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.omtn.2020.04.005","article-title":"Poly (beta-amino ester) nanoparticles enable nonviral delivery of CRISPR-Cas9 plasmids for gene knockout and gene deletion","volume":"20","author":"Rui","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e34692_bib154","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s41563-019-0385-5","article-title":"Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations","volume":"18","author":"Shahbazi","year":"2019","journal-title":"Nat. Mater."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96735-4","article-title":"Bacterial resistance to CRISPR-Cas antimicrobials","volume":"11","author":"Uribe","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34692_bib156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005282","article-title":"Phages fight back: inactivation of the CRISPR-Cas bacterial immune system by anti-CRISPR proteins","volume":"12","author":"Maxwell","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2024.e34692_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.126963","article-title":"Anti-CRISPR proteins as a therapeutic agent against drug-resistant bacteria","author":"Vyas","year":"2022","journal-title":"Microbiol. Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib158","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e34692_bib159","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3389\/fmicb.2018.01352","article-title":"Tunicamycin mediated inhibition of wall teichoic acid affects Staphylococcus aureus and Listeria monocytogenes cell morphology, biofilm formation and virulence","volume":"9","author":"Zhu","year":"2018","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34692_bib160","doi-asserted-by":"crossref","first-page":"e01806","DOI":"10.1128\/mBio.01806-20","article-title":"The unrecognized threat of secondary bacterial infections with COVID-19","volume":"11","author":"Vaillancourt","year":"2020","journal-title":"mBio"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34692_bib161","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1411","article-title":"Short\u2010chain fatty acids profile in patients with SARS\u2010CoV\u20102: a case\u2010control study","volume":"6","author":"Nabizadeh","year":"2023","journal-title":"Health Science Reports"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34692_bib162","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01602-22","article-title":"Engineered bacteriophages containing anti-CRISPR suppress infection of antibiotic-resistant P. aeruginosa","volume":"10","author":"Qin","year":"2022","journal-title":"Microbiol. Spectr."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024107232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024107232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:48:50Z","timestamp":1773841730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024107232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":173,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024107232"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34692","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34692"}}